<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cryopyrin-associated syndromes (CAPS) include three <z:hpo ids='HP_0000006'>autosomal-dominant</z:hpo> syndromes, that are caused by a mutation in the NLRP3 gene on chromosome 1, encoding the cryopyrin protein </plain></SENT>
<SENT sid="1" pm="."><plain>These syndromes, <z:e sem="disease" ids="C1610600" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">familial cold autoinflammatory syndrome</z:e>, <z:e sem="disease" ids="C0268390" disease_type="Disease or Syndrome" abbrv="">Muckle-Wells syndrome</z:e> and <z:hpo ids='HP_0003623'>neonatal-onset</z:hpo> multisystem <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e>, are characterized by <z:hpo ids='HP_0001025'>urticaria</z:hpo>-like <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e>, <z:hpo ids='HP_0001945'>fever</z:hpo>, central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:mp ids='MP_0001845'>inflammation</z:mp>, an <z:hpo ids='HP_0003040'>arthropathy</z:hpo> and a risk of the development of <z:hpo ids='HP_0011034'>amyloidosis</z:hpo> in a respectively escalating degree of severity between the various syndromes </plain></SENT>
<SENT sid="2" pm="."><plain>Recently the role of cryopyrin in the regulation of interleukin (IL)-1 production and activation was described and anti IL-1 therapies were found to be very effective in treating these syndromes </plain></SENT>
<SENT sid="3" pm="."><plain>There are several types of anti IL-1 medications based on different mechanisms of antagonizing IL-1 </plain></SENT>
<SENT sid="4" pm="."><plain>This paper focuses on the efficacy and safety of canakinumab, a long-acting humanized anti IL-1 antibody, in treating these syndromes </plain></SENT>
</text></document>